Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALMIGHTY: Low-dose Rosuvastatin + Ezetimibe vs High-dose Rosuvastatin in CAD
NCT06186037Phase 4Recruiting
- Sponsor
- St Vincent's Hospital
- Start
- Feb 2024
- Primary completion
- Feb 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe in coronary artery disease (CAD), dyslipidemia, sponsored by St Vincent's Hospital. Started Feb 2024; status: recruiting.
02
Drugs
ezetimibe
03
Conditions
coronary artery disease (CAD)dyslipidemia
Beyond the preview
Go deeper on NCT06186037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06186037.